Insider Transactions in Q3 2021 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
10,500
-8.05%
|
$178,500
$17.0 P/Share
|
|
Sep 22
2021
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+7.45%
|
$126,000
$12.15 P/Share
|
|
Sep 15
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,116
-2.53%
|
$46,740
$15.61 P/Share
|
|
Aug 30
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,500
-2.77%
|
$52,500
$15.0 P/Share
|
|
Aug 17
2021
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
2,152
-2.27%
|
$25,824
$12.53 P/Share
|
|
Aug 17
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,579
-2.17%
|
$42,948
$12.53 P/Share
|
|
Aug 17
2021
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,080
-2.27%
|
$24,960
$12.53 P/Share
|
|
Aug 17
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,426
-1.88%
|
$29,112
$12.53 P/Share
|
|
Aug 17
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
8,223
-2.38%
|
$98,676
$12.53 P/Share
|